Medipoint: Percutaneous Coronary Interventions - Global Analysis and Market Forecasts - Product Image

Medipoint: Percutaneous Coronary Interventions - Global Analysis and Market Forecasts

  • ID: 4027374
  • Report
  • Region: Global
  • 101 pages
  • GlobalData
1 of 5
Percutaneous Coronary Interventions Market Will Grow Steadily to Surpass $8 billion by 2022

FEATURED COMPANIES

  • Aachen Resonance
  • Biosensors International
  • Disa Vascular
  • Iramed
  • Micell Technologies
  • Rontis Medical
  • MORE
Coronary artery disease (CAD) is a global public health and socioeconomic problem that affects millions of lives each year. Percutaneous coronary interventions (PCIs) such as stenting and angioplasty have been widely adopted worldwide to treat a range of CAD indications. The market for devices used in PCI is a dynamic and competitive one that is saturated with numerous players trying to gain share by developing innovative technologies.

With the recent introduction and rapidly increasing adoption of innovative technologies such as DEB and BAS, an assessment of the impact of these technologies on the CAD management market is needed. Moreover, more clinical data from randomized clinical trials (RCTs) is now emerging that compares the safety and efficacy of these devices compared to conventional interventional treatment options, and which sheds additional light on the future of CAD management.

Global market for percutaneous coronary interventions, including coronary stents, percutaneous transluminal coronary angioplasty (PTCA) balloons, PTCA drug-eluting balloons (DEB), carotid stents, and renal stents, was valued at approximately $6.3 Billion in 2015. The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 3.5% to reach a valuation of $8.1 Billion in 2022.

Emerging stent technologies in the coronary stent market, including bioabsorbable stents (BASes) and the third generation of DESes with biodegradable polymer/polymer-free coatings, aim to address these unmet needs. The third generation of DESes has been developed to eliminate concerns associated with the permanent polymer coating, which is a cause of late and very late stent thrombosis. Drug-eluting BASes represent the fourth generation in the evolution of DES technology. Given that the stent scaffold degrades over a period of time, BASes offer several benefits, including a reduced risk of restenosis, avoiding the implantation of multiple layers of metal inside the vessel, improving the feasibility of future interventions, and enabling for late lumen gain.

Companies such as B. Braun, Biosensors International, Biotronik, and Terumo are key competitors to these large corporations, as they develop innovative coronary stent platforms. As the next generation of DESes and BASes enter the market, the current key players will need to retain and acquire market share by improving the clinical performance of their existing products. In addition, they will need to expand into or increase their presence in the emerging markets in order to take revenue away from their competitors in the future.

The report “MediPoint: Percutaneous Coronary Interventions - Global Analysis and Market Forecasts” focuses on the market outlook for PCI devices in the 39 major markets (39MM): Canada, Mexico, US, Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey, UK, Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Brazil, Chile, Egypt, Israel, Saudi Arabia, South Africa, and United Arab Emirates.

Specifically, this report provides the following:
  • Overview of percutaneous coronary interventions, including reimbursement trends and M&A analysis
  • Annualized total market revenue by type of device, procedure trends, and market outlooks by country through 2022.
  • Comprehensive data split across different stages of development and analysis of emerging trends in design.
  • Analysis of the current and future market competition in the global percutaneous coronary interventions market. Insightful review of the key industry drivers, opportunities, barriers and challenges.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aachen Resonance
  • Biosensors International
  • Disa Vascular
  • Iramed
  • Micell Technologies
  • Rontis Medical
  • MORE
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Catalyst

2.2 Related Reports

3 Market Access

3.1 Reimbursement Trends

3.1.1 North America

3.1.2 Europe

3.1.3 Asia-Pacific

3.1.4 South America

3.1.5 Middle East and Africa

3.2 Mergers and Acquisitions/Key Partnerships

4 Unmet Needs and Market Opportunity Analysis

4.1 Improving Clinical Outcomes in Complex Coronary Indications

4.1.1 Bifurcation Lesions

4.1.2 Chronic Total Occlusions

4.1.3 Heavily Calcified Lesions

4.1.4 Unprotected Left Main Coronary Artery Lesions

4.1.5 Acute Myocardial Infarction

4.1.6 Saphenous Vein Grafts

4.1.7 Small Vessel Lesions

4.2 Minimizing Late Stent Thrombosis Incidence

4.3 Procedure Optimization

4.4 Reducing Repeat Revascularization Rates

5 Competitive Assessment

5.1 Market Share Analysis

5.2 Key Companies and Product Profiles

5.2.1 Abbott Vascular

5.2.2 B. Braun

5.2.3 Biosensors International

5.2.4 Biotronik

5.2.5 Boston Scientific

5.2.6 Medtronic

5.2.7 Terumo

5.2.8 Other Players

5.3 Pipeline Products Assessment

5.4 Clinical Trials Assessment

6 Market Outlook

6.1 Procedure Trends

6.2 Global Market Drivers and Barriers

6.2.1 Driver: Rising Disease Prevalence

6.2.2 Driver: Launch of Bioabsorbable Stents on a Global Scale

6.2.3 Driver: Reducing Need for Antiplatelet Therapy

6.2.4 Barrier: Risk of Perioperative Adverse Cardiac Events Post-Stenting

6.2.5 Barrier: Post-ProceduraI Complications of Drug-Eluting Stenting

6.2.6 Barrier: Concerns Regarding Overstenting

6.3 Market Outlooks by Segment

6.3.1 Coronary Stents

6.3.2 Percutaneous Transluminal Coronary Angioplasty Balloons

6.3.3 Percutaneous Transluminal Angioplasty Drug-Eluting Balloons

6.4 Market Outlooks by Geography

6.4.1 Global Overview

6.4.2 North America

6.4.3 Europe

6.4.4 Asia-Pacific

6.4.5 South America

6.4.6 Middle East and Africa

7 Appendix

7.1 Bibliography

7.2 Abbreviations

7.3 Methodology

7.3.1 Overview

7.3.2 Coverage

7.3.3 Secondary Research

7.4 Forecasting Methodology

7.5 Primary Research Summary

7.6 About the Authors

7.6.1 Premdharan Meyyan, Cardiovascular Analyst, Medical Devices

7.6.2 Linda Tian, Msc, Managing Analyst, Medical Devices

7.6.3 Tyler Fletcher, Global Head of Medical Devices

7.7 About

1.1 List of Tables

Table 1: Medicare National Average of Inpatient Hospital Reimbursement for Percutaneous Coronary Interventions, 2015-2016

Table 2: Hospital Outpatient Reimbursement for Percutaneous Coronary Interventions, 2015

Table 3: Key Mergers, Acquisitions, and Partnerships in Percutaneous Coronary Interventions Market

Table 4: Complex Coronary Indications and Estimated Incidence

Table 5: Abbott Vascular - Company SWOT Analysis

Table 6: Abbott Vascular - Marketed Products Assessment

Table 7: B. Braun - Company SWOT Analysis

Table 8: B. Braun - Marketed Products Assessment

Table 9: Biosensors International - Company SWOT Analysis

Table 10: Biosensors International - Marketed Products Assessment

Table 11: Biotronik - Company SWOT Analysis

Table 12: Biotronik - Marketed Products Assessment

Table 13: Boston Scientific - Company SWOT Analysis

Table 14: Boston Scientific - Marketed Products Assessment

Table 15: Medtronic - Company SWOT Analysis

Table 16: Medtronic - Marketed Products Assessment

Table 17: Terumo - Company SWOT Analysis

Table 18: Terumo - Marketed Products Assessment

Table 19: Other Players Assessment

Table 20: Pipeline Products Assessment

Table 21: Clinical Trials Assessment

Table 22: Global Percutaneous Coronary Interventions Procedures Forecast ($m), 2013-2022

Table 23: Global Coronary Stents Market Forecast ($m), 2013-2022

Table 24: Global PTCA Balloons Market Forecast ($m), 2013-2022

Table 25: Global PTCA DEB Market Forecast ($m), 2013-2022

Table 26: Global Coronary Stents Market Forecast ($m), 2013-2022

Table 27: North America PCI Market Forecast ($m), 2013-2022

Table 28: Europe PCI Market Forecast ($m), 2013-2022

Table 29: Asia-Pacific Percutaneous Coronary Interventions Market Forecast ($m), 2013-2022

Table 30: South America PCI Market Forecast ($m), 2013-2022

Table 31: Middle East & Africa PCI Market Forecast ($m), 2013-2022

1.2 List of Figures

Figure 1: Proportion of Patients Undergoing Repeat Revascularization, by Revascularization Subtype

Figure 2: 10MM Market Shares for Coronary Stents, by Country, 2015

Figure 3: Global PCI Procedures Forecast, by Region, 2013-2022

Figure 4: Global Coronary Stents Market Forecast ($m), 2013-2022

Figure 5: Coronary Stents Market Comparison, by Segment, 2015 and 2022

Figure 6: Global PTCA Balloons Market Forecast ($m), 2013-2022

Figure 7: PTCA Balloons Market Comparison, by Segment, 2015 and 2022

Figure 8: Global PTCA DEB Market Forecast ($m), 2013-2022

Figure 9: Global PCI Market Forecast ($m), by Region, 2013-2022

Figure 10: North America PCI Market Forecast ($m), by Segment, 2013-2022

Figure 11: Europe PCI Market Forecast ($m), by Segment, 2012-2022

Figure 12: APAC PCI Market Forecast ($m), by Segment, 2013-2022

Figure 13: South America PCI Market Forecast ($m), by Segment, 2013-2022

Figure 14: Middle East & Africa PCI Market Forecast ($m), by Segment, 2013-2022

Figure 15: Percutaneous Coronary Survey Primary Research Participants, by Country
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Aachen Resonance
  • Biosensors International
  • Disa Vascular
  • Iramed
  • Micell Technologies
  • Rontis Medical
  • MORE
Percutaneous coronary interventions market will grow steadily to surpass $8 billion by 2022.

The global market for percutaneous coronary interventions, which covers coronary stents, percutaneous transluminal coronary angioplasty (PTCA) balloons, PTCA drug-eluting balloons, carotid stents and renal stents, is forecast to grow from $6.3 billion in 2015 to $8.1 billion by 2022, at a compound annual growth rate of 3.5%.

The company’s latest report states that this steady growth, which covers the market in 39 countries, will be driven by rising disease prevalence and improving technologies. Over the years, an array of bare metal stents (BMS) and drug-eluting stents (DES) have been developed, featuring innovative materials, designs, structures, coatings, and drug-elution components.

Premdharan Meyyan, Analyst covering Medical Devices, explains: “The development and optimization of DESes has become a primary focus for many stent manufacturers, where they utilize the BMSes they have developed as the platform and foundation for their DESes. These innovations in technology aim to ensure high radial strength and flexibility, low elastic recoil, optimal vessel coverage, minimal foreshortening, and rapid strut endothelialization.”

The coronary stents market is vast and dynamic, and is saturated with numerous players worldwide. The competitive landscape consists of large, mid-size, and small companies that have developed different types of coronary stents to target various indications. However, a few key players dominate the market, including Abbott Vascular, Medtronic, and Boston Scientific.

Meyyan continues: “As the next generation of DESes and BASes enter the market, the current key players will need to retain and acquire market share by improving the clinical performance of their existing products. In addition, they will need to expand into or increase their presence in emerging markets in order to take revenue away from their competitors in the future."

In terms of regional variations in the coronary interventions space, the US, France, Germany, Italy, Spain, and the UK markets are expected to slowly decline in value in the future. As medical costs continue to rise, healthcare providers are implementing cost-containment policies and ‘appropriateness criteria’ to reduce costs and overstenting.

Meyyan concludes: “Unlike in the West, the coronary stents markets in the Asia-Pacific and South American regions are expected to demonstrate steady growth in the future. The APAC countries, including Japan, China, and India, have diverse populations, ethnicities, and clinical practices. Most device manufacturers regard Japan and China as their chief targets, due to their economic growth, pricing structure, and vast populations.”
- Comments provided by Premdharan Meyyan, Analyst covering Medical Devices.
- Information based on the report: MediPoint: Percutaneous Coronary Interventions - Global Analysis and Market Forecasts.
- This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by a team of industry experts.
Note: Product cover images may vary from those shown
5 of 5
  • Aachen Resonance
  • Abbott Vascular
  • Alvimedica
  • amg International
  • B. Braun
  • Balton
  • Biosensors International
  • Biotronik
  • Blue Medical
  • Boston Specific
  • Cardionovum
  • Concept Medical
  • Disa Vascular
  • Elixir Medical
  • Eucatech
  • Eurocor
  • Hexacath
  • InSitu Technologies
  • Iramed
  • ITGI Medical
  • JW Medical Systems
  • Kyoto Medical Planning
  • Lepu Medical Technology
  • Medinol
  • Medtronic ,Meril Life Sciences
  • Micell Technologies
  • MicroPort
  • Minvasys
  • MIV Therapeutics
  • OrbusNeich
  • Relisys
  • Rontis Medical
  • Sahajanand Medical Technologies
  • Stentys
  • Svelte Medical Systems
  • Terumo
  • Translumina
  • Tryton Medical
  • Vascular Concepts
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll